On our website, we would like to use the services of third-party providers who help us improve our promotional offerings (marketing), evaluate the use of our website (performance) and adapt the website to your preferences (functionality). We need your consent for the use of these services; you can always revoke this consent. You can find information about the services and the chance to reject them under “User-defined.” You can find additional information in our Data Protection Policy.

New: 17 - 19 February 2021 // eSPECIAL

Posting print layout

What information should be shown in the print layout?

Create print layout
Exhibitors & Products BIOFACH 2020

ADSI GmbH

Innrain 66a

6020 Innsbruck

Austria

Phone: +43(0)512.50736301

Halle

VIVANESS 2020

Other exhibitors (9)

High Content Screening with customized, clinically relevant assays

ADSI, the Austrian Drug Screening Institute, is a research company of the Leopold-Franzens-University Innsbruck (LFU) and offers contract research for companies and academic research institutes. The unique feature about ADSI is that cell-based assays are tailored to be particularly clinically relevant. On the other hand, these assays are read out with High Content Content Screening with regard to as many parameters as possible. This enables scanning focused substance libraries quickly and systematically for effective candidates (hits) for a wide variety of medical questions. We offer new analytical approaches for Phytopharmacy, Phytocosmetics and Phytonutrition.

Drug candidates with better opportunities

ADSI does not limit itself to answering the question: does it work or not. ADSI provides an explanation of how and why a substance works and whether side effects are to be expected. This information will help to better assess the potential of compounds for clinical trials. With this concept ADSI offers not only an ideal platform for finding drug candidates, but also a special environment to accurately characterize and further develop the first hits from a previous high throughput screening (Hit to Lead).

Co-cultures, analytics and toxicity tests

The particular strengths of ADSI are evident at all levels of early drug development:

  • Special extraction processes and chemical analysis make it possible to optimize the production of effective substance mixtures, especially plant extracts.
  • The screening of co-cultures consisting of different cell types is carried out under controlled oxygen conditions. The cell systems are also monitored over a long period of time using state-of-the-art analytical methods in order to investigate the influence of test substances on cell communication and signal transduction as well as to elucidate what happens to the test substances in cell metabolism.
  • Toxicological tests provide initial information on the tolerance of test substances. This results in a profound, meaningful and trend-setting screening result for further development.

ADSI GmbH offers you products from these product groups:

Sector

Search option for distribution channels via the sector filter.



top

The selected entry has been placed in your favourites!

If you register you can save your favourites permanently and access all entries even when underway – via laptop or tablet.

You can register an account here to save your settings in the Exhibitors and Products Database and as well as in the Supporting Programme.The registration is not for the TicketShop and ExhibitorShop.

Register now

Your advantages at a glance:

  • Advantage Save your favourites permanently. Use the instant access – mobile too, anytime and anywhere – incl. memo function.
  • Advantage The optional newsletter gives you regular up-to-date information about new exhibitors and products – matched to your interests.
  • Advantage Call up your favourites mobile too! Simply log in and access them at anytime.